Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients-Reference-Cited by-同舟云学术

Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients

Published:2015-12-30 Issue:5 Volume:23 Page:1699-1707
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Ruzzenente Andrea,Fassan Matteo,Conci Simone,Simbolo Michele,Lawlor Rita T.,Pedrazzani Corrado,Capelli Paola,D’Onofrio Mirko,Iacono Calogero,Scarpa Aldo,Guglielmi Alfredo

Funder

FP7 EU project CAM-PaC

Ministero dell'Istruzione, dell'Università e della Ricerca

Agenzia Italiana del Farmaco, Ministero della Salute

Associazione Italiana per la Ricerca sul Cancro

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-015-5046-6.pdf

Reference26 articles.

1. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999;341:1368–78.

2. Patel T. Cholangiocarcinoma—controversies and challenges. Nat Rev Gastroenterol Hepatol. 2011;8:189–200.

3. International Union Against Cancer (UICC). TNM classification of malignant tumours. 7th ed. Chichester: Wiley-Blackwell; 2010.

4. American Joint Committee on Cancer (AJCC). Cancer staging manual. 7th ed. New York: Springer; 2010.

5. Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol. 2008;15:590–9.

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells;Gastroenterology;2024-08

2. Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review;Surgery Today;2024-04-02

3. GDF11: An emerging therapeutic target for liver diseases and fibrosis;Journal of Cellular and Molecular Medicine;2024-03-17

4. Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma;Cancers;2024-02-07

5. An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report;Frontiers in Oncology;2023-08-22